Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E S Kilpatrick

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Annals of Clinical Biochemistry|September 18, 1997
Pseudohyperkalaemia, pseudohyponatraemia and pseudohypoglycaemia in a patient with hereditary stomatocytosisE S Kilpatrick, I D Burton
Heart (British Cardiac Society)|January 20, 2005
Evidence of gender bias when applying the new diagnostic criteria for myocardial infarctionS A Madrid Willingham, E S Kilpatrick
Epilepsia|June 1, 1996
Concentration--effect and concentration--toxicity relations with lamotrigine: a prospective studyE S Kilpatrick, G Forrest, M J Brodie
QJM : Monthly Journal of the Association of Physicians|April 1, 1996
The effects of ageing on glycation and the interpretation of glycaemic control in Type 2 diabetesE S Kilpatrick, M H Dominiczak, M Small
Annals of Clinical Biochemistry|April 11, 2014
LDL cholesterol variability in patients with Type 2 diabetes taking atorvastatin and simvastatin: a comparison of two formulae for LDL-C estimationT Sathyapalan, S L Atkin, E S Kilpatrick
Annals of Clinical Biochemistry|June 28, 2007
Stability of creatinine with delayed separation of whole blood and implications for eGFRJ Shepherd, M H Warner, E S Kilpatrick
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2005
Improvement of glycaemic control with rebound following orlistat initiation and cessation associated with minimal weight changeS González, E S Kilpatrick, S L Atkin
Diabetes, Obesity & Metabolism|June 4, 2010
Low density lipoprotein-cholesterol variability in patients with type 2 diabetes taking atorvastatin compared to simvastatin: justification for direct measurement?T Sathyapalan, S L Atkin, E S Kilpatrick
Diabetic Medicine : a Journal of the British Diabetic Association|October 31, 2008
Variability of lipids in patients with Type 2 diabetes taking statin treatment: implications for target settingT Sathyapalan, S L Atkin, E S Kilpatrick
Diabetic Medicine : a Journal of the British Diabetic Association|June 1, 1994
Variations in sample pH and pO2 affect ExacTech meter glucose measurementsE S Kilpatrick, A G Rumley, E A Smith
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Annals of Clinical Biochemistry|September 18, 1997
Pseudohyperkalaemia, pseudohyponatraemia and pseudohypoglycaemia in a patient with hereditary stomatocytosisE S Kilpatrick, I D Burton
Heart (British Cardiac Society)|January 20, 2005
Evidence of gender bias when applying the new diagnostic criteria for myocardial infarctionS A Madrid Willingham, E S Kilpatrick
Epilepsia|June 1, 1996
Concentration--effect and concentration--toxicity relations with lamotrigine: a prospective studyE S Kilpatrick, G Forrest, M J Brodie
QJM : Monthly Journal of the Association of Physicians|April 1, 1996
The effects of ageing on glycation and the interpretation of glycaemic control in Type 2 diabetesE S Kilpatrick, M H Dominiczak, M Small
Annals of Clinical Biochemistry|April 11, 2014
LDL cholesterol variability in patients with Type 2 diabetes taking atorvastatin and simvastatin: a comparison of two formulae for LDL-C estimationT Sathyapalan, S L Atkin, E S Kilpatrick
Annals of Clinical Biochemistry|June 28, 2007
Stability of creatinine with delayed separation of whole blood and implications for eGFRJ Shepherd, M H Warner, E S Kilpatrick
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2005
Improvement of glycaemic control with rebound following orlistat initiation and cessation associated with minimal weight changeS González, E S Kilpatrick, S L Atkin
Diabetes, Obesity & Metabolism|June 4, 2010
Low density lipoprotein-cholesterol variability in patients with type 2 diabetes taking atorvastatin compared to simvastatin: justification for direct measurement?T Sathyapalan, S L Atkin, E S Kilpatrick
Diabetic Medicine : a Journal of the British Diabetic Association|October 31, 2008
Variability of lipids in patients with Type 2 diabetes taking statin treatment: implications for target settingT Sathyapalan, S L Atkin, E S Kilpatrick
Diabetic Medicine : a Journal of the British Diabetic Association|June 1, 1994
Variations in sample pH and pO2 affect ExacTech meter glucose measurementsE S Kilpatrick, A G Rumley, E A Smith
Pageof 8